PubRank

Hironori Sato

Author PubWeight™ 54.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. Clin Infect Dis 2005 1.58
2 Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility. J Virol 2010 1.37
3 A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J Virol 2007 1.32
4 Identification of monomorphic and divergent haplotypes in the 2006-2007 norovirus GII/4 epidemic population by genomewide tracing of evolutionary history. J Virol 2008 1.26
5 Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. Nat Struct Mol Biol 2008 1.21
6 Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity. PLoS One 2008 1.07
7 Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J Virol 2010 1.07
8 Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor. J Virol 2005 1.05
9 Structural and biological constraints on diversity of regions immediately upstream of cleavage sites in calicivirus precursor proteins. Virology 2009 0.99
10 Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction. Retrovirology 2010 0.97
11 Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages. AIDS Res Hum Retroviruses 2002 0.95
12 HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine 2010 0.95
13 CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B. PLoS One 2011 0.93
14 The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions. Retrovirology 2014 0.92
15 Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals. Int Immunopharmacol 2004 0.92
16 Structural dynamics of HIV-1 envelope Gp120 outer domain with V3 loop. PLoS One 2012 0.91
17 Ezrin, Radixin, and Moesin (ERM) proteins function as pleiotropic regulators of human immunodeficiency virus type 1 infection. Virology 2008 0.90
18 Relationship between the curvature constant parameter of the power-duration curve and muscle cross-sectional area of the thigh for cycle ergometry in humans. Eur J Appl Physiol 2002 0.90
19 Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies. J Virol 2005 0.89
20 Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs. Clin Vaccine Immunol 2012 0.89
21 Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS 2002 0.89
22 Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol 2013 0.89
23 Highly conserved configuration of catalytic amino acid residues among calicivirus-encoded proteases. J Virol 2007 0.88
24 Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes Infect 2012 0.87
25 Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection. Virology 2009 0.87
26 [A case of cardiac myxoma presenting with multiple cerebellar hemorrhages and elevation of interleukin-6 in the cerebrospinal fluid]. Rinsho Shinkeigaku 2004 0.87
27 A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α. PLoS One 2011 0.87
28 Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine. Antimicrob Agents Chemother 2010 0.87
29 Molecular dynamics simulation in virus research. Front Microbiol 2012 0.87
30 Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses. J Virol 2013 0.86
31 A proposal for a new HIV-1 DLS structural model. Nucleic Acids Res 2012 0.86
32 A structural constraint for functional interaction between N-terminal and C-terminal domains in simian immunodeficiency virus capsid proteins. Retrovirology 2010 0.84
33 The indonesian variants of CRF33_01B: Near-full length sequence analysis. AIDS Res Hum Retroviruses 2010 0.84
34 Systemic biological analysis of the mutations in two distinct HIV-1mt genomes occurred during replication in macaque cells. Microbes Infect 2013 0.84
35 Higher levels of IL-18 circulate during primary infection of monkeys with a pathogenic SHIV than with a nonpathogenic SHIV. Virology 2003 0.83
36 TRIM5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1. J Gen Virol 2013 0.83
37 The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement. PLoS One 2011 0.83
38 Structural basis for specific recognition of substrates by sapovirus protease. Front Microbiol 2012 0.83
39 [A case of postpartum cerebral angiopathy with intracranial hemorrhage and subarachnoid hemorrhage immediately after delivery]. Rinsho Shinkeigaku 2005 0.82
40 Structure and dynamics of the gp120 V3 loop that confers noncompetitive resistance in R5 HIV-1(JR-FL) to maraviroc. PLoS One 2013 0.82
41 Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication. J Virol 2003 0.82
42 Cooperative contribution of gag substitutions to nelfinavir-dependent enhancement of precursor cleavage and replication of human immunodeficiency virus type-1. Antiviral Res 2006 0.82
43 Current HIV type 1 molecular epidemiology profile and identification of unique recombinant forms in Jakarta, Indonesia. AIDS Res Hum Retroviruses 2009 0.82
44 The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. PLoS One 2012 0.82
45 Within-host co-evolution of Gag P453L and protease D30N/N88D demonstrates virological advantage in a highly protease inhibitor-exposed HIV-1 case. Antiviral Res 2011 0.81
46 Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. Biochem Biophys Res Commun 2007 0.80
47 A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs. Biochem Biophys Res Commun 2012 0.80
48 Arginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism. Sci Rep 2013 0.80
49 Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability. J Virol 2014 0.79
50 Inhibitory role of CXCR4 glycan in CD4-independent X4-tropic human immunodeficiency virus type 1 infection and its abrogation in CD4-dependent infection. J Gen Virol 2007 0.79
51 Identification of folding preferences of cleavage junctions of HIV-1 precursor proteins for regulation of cleavability. J Mol Model 2010 0.79
52 Dissociation between the time courses of femoral artery blood flow and pulmonary VO2 during repeated bouts of heavy knee extension exercise in humans. Exp Physiol 2004 0.79
53 Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance. AIDS 2010 0.79
54 Retrovirus entry by endocytosis and cathepsin proteases. Adv Virol 2012 0.79
55 Identification of amino acid residues in HIV-1 reverse transcriptase that are critical for the proteolytic processing of Gag-Pol precursors. FEBS Lett 2011 0.79
56 Molecular and enzymatic characterization of XMRV protease by a cell-free proteolytic analysis. J Proteomics 2012 0.78
57 Autonomic nervous activities assessed by heart rate variability in pre- and post-adolescent Japanese. J Physiol Anthropol 2009 0.78
58 SIRT1 deacetylates RORγt and enhances Th17 cell generation. J Exp Med 2015 0.76
59 VO2 response at the onset of heavy exercise is accelerated not by diathermic warming of the thigh muscles but by prior heavy exercise. Res Sports Med 2012 0.76
60 Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues. Bioorg Med Chem 2011 0.76
61 CXCR4-tropic, but not CCR5-tropic, human immunodeficiency virus infection is inhibited by the lipid raft-associated factors, acyclic retinoid analogs, and cholera toxin B subunit. AIDS Res Hum Retroviruses 2012 0.76
62 A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytes. J Virol 2012 0.76
63 Allosteric regulation of HIV-1 reverse transcriptase by ATP for nucleotide selection. PLoS One 2010 0.76
64 Tertiary mutations stabilize CD8+ T lymphocyte escape-associated compensatory mutations following transmission of simian immunodeficiency virus. J Virol 2013 0.75
65 Blood pressure monitor with a position sensor for wrist placement to eliminate hydrostatic pressure effect on blood pressure measurement. Conf Proc IEEE Eng Med Biol Soc 2013 0.75
66 A cross-sectional ultrasound imaging for measuring body composition. Conf Proc IEEE Eng Med Biol Soc 2007 0.75
67 Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs. J Infect Chemother 2013 0.75
68 [A mechanism of norovirus pandemic based on comprehensive genome analysis]. Kansenshogaku Zasshi 2012 0.75
69 Physical activity group classification algorithm using triaxial acceleration and heart rate. Conf Proc IEEE Eng Med Biol Soc 2015 0.75
70 Improvement in the Quality of Life and Exercise Performance in Relation to the Plasma B-Type Natriuretic Peptide Level After Catheter Ablation in Patients With Asymptomatic Persistent Atrial Fibrillation. Circ J 2017 0.75
71 [A case of aphasia with preserved repetition due to anterior choroidal artery territory infarction]. Rinsho Shinkeigaku 2005 0.75
72 Effect of aerobic leg exercise training on subcutaneous adipose tissue of thigh in young Japanese women. J Physiol Anthropol 2009 0.75
73 [A case of heparin-induced thrombocytopenia that worsened preexisting cerebral infarction]. Rinsho Shinkeigaku 2004 0.75
74 [Sensory disturbance in the pulp of the fingertips in three patients with cervical myelitis]. Rinsho Shinkeigaku 2006 0.75
75 [Skin collagen abnormalities in a Japanese patient with extracranial internal carotid artery dissection followed by extracranial vertebral artery dissection]. Rinsho Shinkeigaku 2006 0.75
76 Low hemagglutinin-titer strains of pandemic influenza A (H1N1) 2009 virus circulated in Toyama Prefecture, Japan, during the 2009-2011 influenza seasons. Jpn J Infect Dis 2011 0.75